Osaka Saiseikai Izuo Hospital Uses Vuzix M400 Smart Glasses to Provide Remote Medical Support

Vuzix smart glasses provide critical support in difficult to reach infectious disease zones of hospitals

 

ROCHESTER, NY, March 29, 2022 – Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that Osaka Saiseikai Izuo Hospital, based in Osaka, Japan, is using Vuzix M400 smart glasses to provide remote medical support within the hospital’s infectious zone areas.

 

Vuzix smart glasses supporting medical personnel in the red zone at Osaka Saiseikai Izuo Hospital

 

Within the hospital’s inpatient ward for patients with infectious diseases, zoning is used to divide the area into pathogen contaminated (red zone) and uncontaminated sanitary (green zone). Health care professionals need to wear personal protective equipment when going into the red zone. The hospital was able to function efficiently with a limited number of staff members working within the red zone by using Vuzix smart glasses running the Zoom application to remotely convey information vocally and visually, as well as to receive instructions.

 

One use case is supporting the ability to double-check the medications and treatments used in the red zone by communicating with the doctors and medical staff located in the green zone. Another is remotely supporting the operation and the problems related to using advanced medical equipment. In this instance, clinical engineers would be able to participate in treatments remotely while operating advanced medical equipment, such as mechanical ventilators and extracorporeal membrane oxygenators (ECMO). Additionally, the hospital believes that the glasses can be used not only within their infectious ward, but also for a wider variety of areas including education and telemedicine.

 

“With their high-performance specs, all-day wearability and hands-free operation, Vuzix smart glasses are tailor-made for use within hospitals and for telemedicine in general," said Paul Travers, President and Chief Executive Officer at Vuzix. “We are seeing more and more doctors and hospitals and around the world testing and adopting our smart glasses and we look forward to working further with customers like Osaka Saiseikai Izuo Hospital to make their day-to-day operations safer and more productive.”

 

About Vuzix Corporation

Vuzix is a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company's products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 245 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2022 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan.  For more information, visit the Vuzix websiteTwitter and Facebook pages.

 

Forward-Looking Statements Disclaimer

Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to Vuzix Smart Glasses, our business relationship and future opportunities with Osaka Saiseikai Izuo Hospital, and among other things the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

 

Vuzix Media and Investor Relations Contact:

Ed McGregor, Director of Investor Relations,

Vuzix Corporation

ed_mcgregor@vuzix.com  

Tel: (585) 359-5985

 

Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,

Investor Information – IR@vuzix.com  www.vuzix.com